Level Cannabis Brand Logo

Level

Data Snapshot: Jul 04, 2026
$500K+

Jun-2026

Sales

Decline

Trend

6-Month

124

Product Count

SKUs

$18.36

Avg Price

-57.4%

YoY Sales Change

4.7%

YoY Price Change

LEVEL is a renowned, privately-owned cannabis company that stands at the vanguard of cannabinoid research and innovation, formulating targeted, effects-based cannabis experiences. Distinguished by their advanced understanding and application of cannabinoids and terpenoids, Level I cultivators are granted permission to initiate marijuana cultivation, meeting rigid security requirements for site research. While fully committed to consumer safety measures, the company also facilitates a comprehensive understanding of cannabis, offering reliable information about the differences between THC and CBD, the health implications, and the company's diverse cannabis strains.
Level Sales

Market Insights Snapshot

Level Historical Sales by Category

In June 2026, Level’s mix is overwhelmingly concentrated in Capsules at 99.94% share, with Capsules down 57.47% year over year and down 7.99% month over month, while the residual Flower presence holds just 0.06% share with no established YoY or MoM trend. The brand’s overall average price rose 4.73% YoY to $18.36, and Capsules specifically averaged $18.36, indicating pricing stability amid volume contraction, while the negligible Flower average price of $21.95 has minimal impact on mix. With Capsules occupying the number 1 rank in Nevada, the combination of a steep YoY decline and a smaller MoM drop implies the category remains the engine of the franchise but is relying on price firmness rather than breadth of demand growth.

The narrowing toward a single-category footprint—99.94% in Capsules alongside a 57.45% brand-level YoY sales contraction and a 7.99% MoM slide—implies heightened exposure to Capsules demand cycles and limited insulation from adjacent categories. Holding the top rank in Nevada while prices rise 4.73% YoY suggests positioning anchored in perceived product value that may defend share in rank terms but risks volume sensitivity when Capsule demand softens; the 0.06% Flower share provides little hedge, so near-term positioning depends on stabilizing Capsule velocities rather than mix diversification.

Jun-2026 Rank
Capsules
3
1
2
Category
Share of Sales
Avg Item Price
YoY %
MoM %
Capsules
99.9%
$18.36
-57.5%
-8.0%
Flower
0.1%
$21.95
Level

Competitive Landscape

Level sits at #3 in California Capsules in June 2026, down 2 positions from its #1 peak in January 2026 but up 2 spots from #5 a year ago, while sliding 1 rank from #2 three months ago implies near-term slippage against the field; in contrast, Breez climbed from #2 to #1 year over year despite a 36.98% sales decline, and ABX / AbsoluteXtracts moved from #3 to #2 with a 23.27% YoY sales drop, indicating Level’s relative momentum is rank-stable versus weakening leaders but not converting into share-taking since Emerald Bay Extracts improved from #5 to #4 while Buddies advanced from #6 to #5 on 29.83% YoY growth; the pattern implies Level’s trajectory is mid-pack durable but requires a catalyst to reclaim #1 as competitors with declining sales still edge it on rank.

Level market ranking for CA Capsules

Level

Notable Products

Protab - Sativa Extra Strength Tablets 10-Pack (250mg) posted the steepest decline at -18.2% and fell to rank 4, while Hashtab - Indica Tablets 10-Pack (250mg) slid -12.9% at rank 6; in contrast, Protab+ - Lights Out Tablets 10-Pack gained 19.0% at rank 3. Protab - Sativa Profesional Strength Tablet (100mg) climbed 39.5% to rank 2 as Protab - Indica Tablet (100mg) inched up 4.8% at rank 1, and six of the top ten are Capsules from the Protab family, concentrating share in a narrow format. The mix shows demand rotating toward standard-strength Protab SKUs over extra- and hash-strength formats, pointing Level toward reinforcing core Protab dosing tiers and sleep-forward formulations rather than pushing higher milligram variants.

Product
Category
Feb-2026
Mar-2026
Apr-2026
May-2026
Jun-2026
MoM %
Protab - Indica Tablet (100mg)
Capsules
1
1
1
1
1
+4.8%
Protab - Sativa Profesional Strength Tablet (100mg)
Capsules
4
2
2
2
2
+39.5%
Protab+ - Lights Out Tablets 10-Pack (50mg CBN, 20mg CBG, 200mg Delta-9 THC, 50mg Delta-8 THC, 20mg THCA)
Capsules
2
3
4
4
3
+19.0%
Protab - Sativa Extra Strength Tablets 10-Pack (250mg)
Capsules
5
4
3
3
4
-18.2%
Protab - Indica Extra Strength Tablets 10-Pack (250mg)
Capsules
3
5
5
8
5
+1.5%
Hashtab - Indica Tablets 10-Pack (250mg)
Capsules
6
6
6
5
6
-12.9%
Hashtab 100 - Sativa Tablet (100mg)
Capsules
9
10
9
7
7
-18.0%
Protab Max - Indica Strength Tablet 2-Pack (100mg)
Capsules
>10
8
>10
>10
8
Protab+ - THC/THCv/CBG Boost Tablets 10-Pack (200mg THC, 70mg THCv, 30mg CBG)
Capsules
7
9
7
6
9
-18.2%
Hashtab 100 - Indica Tablet (100mg)
Capsules
10
>10
10
>10
10
View product & sales data

Top Selling Cannabis Brands

Simple, transparent pricing that grows with you.
Research the top cannabis brands across markets in the US and Canada.

Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.

Header image
User rating
start Today
Stay ahead of the competition with real-time market data insights.

Discover How Your Brand Stacks Up in the Market